Galmed Pharmaceuticals Ltd. (EOCN) — Institutional Holders, Q2 2026
14 institutional investment managers reported a EOCN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $62.9K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
EOCN in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSAdded · +75,469 sh+$42.1K
- SBI Securities , Ltd.Added · +50 sh+$28.00
Biggest sellers
- TWO SIGMA INVESTMENTSSold out · -80,177 sh-$44.8K
- JANE STREET GROUPSold out · -16,445 sh-$9.2K
- XTX Topco LtdTrimmed · -7,381 sh-$4.1K
- UBS Group AGTrimmed · -2,543 sh-$1.4K
- TWO SIGMA SECURITIESTrimmed · -959 sh-$535.00
EOCN 13F holders ranked 1–14 of 14
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 86,851 sh | 86,851 | $48.3K | 0.00% | +663.1% |
| 2 | XTX Topco Ltd#2 · 15,015 sh | 15,015 | $8.4K | <0.01% | -33.0% |
| 3 | TWO SIGMA SECURITIES#3 · 11,012 sh | 11,012 | $6.1K | <0.01% | -8.0% |
| 4 | SBI Securities , Ltd.#4 · 66 sh | 66 | $37.00 | — | +312.5% |
| 5 | MORGAN STANLEY#5 · 56 sh | 56 | $31.00 | 0.00% | -64.3% |
| 6 | WELLS FARGO & COMPANY#6 · 43 sh | 43 | $24.00 | 0.00% | 0.0% |
| 7 | HRT FINANCIAL#7 · 42,090 sh | 42,090 | $23.00 | 0.00% | New |
| 8 | Federation des caisses Desjardins du Quebec#8 · 14 sh | 14 | $8.00 | 0.00% | 0.0% |
| 9 | Allworth Financial#9 · 2 sh | 2 | $2.00 | 0.00% | 0.0% |
| 10 | UBS Group AG#10 · 3 sh | 3 | $2.00 | 0.00% | -99.9% |
| 11 | OSAIC#11 · 5 sh | 5 | $2.00 | 0.00% | 0.0% |
| 12 | ZRC WEALTH MANAGEMENT#12 · 1 sh | 1 | $1.00 | — | 0.0% |
| 13 | ROYAL BANK OF CANADA#13 · 550 sh | 550 | $0.00 | 0.00% | New |
| 14 | TSFG#14 · 17 sh | 17 | $0.00 | — | 0.0% |
Funds that sold out of EOCN in Q2 2026 (4)
Held EOCN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| TWO SIGMA INVESTMENTS80,177 sh | 80,177 | $39.3K |
| JANE STREET GROUP16,445 sh | 16,445 | $8.1K |
| BNP PARIBAS FINANCIAL MARKETS600 sh | 600 | $294.00 |
| Dogwood Wealth Management1 sh | 1 | $0.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.